Global Health Investment Corporation — Full Portfolio
5 tracked investments · listed companies and verified rows first
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina D. Smolke(Executive Officer, Director)inChristina Smolke(Co-Founder & CEO)inKristy Hawkins(Co-Founder & CSO)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
Co-investorsAmerica's Frontier FundCivilization Ventures Management, LlcLam CapitalSherpalo Ventures
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesAthosCivilization Ventures Management, LlcIn-Q-TelSherpalo VenturesViking Global Investors
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Micron BiomedicalUnivercells’s websiteVaxess Technologies, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.